Business
Investor presentation - change of venue
Investor presentation - change of venue.
About this update from Optibiotix Health Plc
[{"type":"text","content":"\n \nRNS Number : 3267N OptiBiotix Health PLC 28 January 2016 \n\nOptiBiotix Health Plc\n(the \"Company\" or the \"Group\")\n \nInvestor Presentation - Change of venue\n \nOptiBiotix Health plc (AIM: OPTI), a Life Sciences business developing compounds to tackle obesity, high cholesterol and diabetes, announces a change of venue for the presentation for investors due to take place on Tuesday, 16 February 2016.\n \nDue to popular demand, the event will now be held in the Oriental room at the London Capital Club, 15 Abchurch Lane, London EC4N 7BW from 4.30pm for a 4.45pm start.\n \nAll other details remain the same as stated in the RNS published on 20 January 2016. \n \nTo register for the event, please email [email protected] or call the Walbrook PR team below. If you have already registered, you need not take any further action. \n \n \n\n\n\n\nOptiBiotix Health plc\n\n\nwww.optibiotix.com\n\n\n\n\nStephen O'Hara, Chief Executive\n\n\nContact via Walbrook below\n\n\n\n\n\n\n\n\n\n\n\n\nCairn Financial Advisers LLP\n\n\nTel: 020 7148 7900\n\n\n\n\nLiam Murray / Avi Robinson\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nHybridan LLP (Joint Broker)\nClaire Louise Noyce\n \n\n\nTel: 020 3764 2341\n\n\n\n\nPeterhouse Corporate Finance Ltd (Joint Broker)\n\n\nTel: 020 7469 0936\n\n\n\n\nLucy Williams / Duncan Vasey\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWalbrook PR Ltd\n\n\nTel: 020 7933 8780 or [email protected] \n\n\n\n\nAnna Dunphy\n\n\nMob: 07876 741 001\n\n\n\n\nMike Wort\n\n\nMob: 07900 608 002\n\n\n\n\n \n \nAbout OptiBiotix Health PLC - www.optibiotix.com \nOptiBiotix was formed in March 2012 to develop compounds which modify the human microbiome - the collective genome of the microbes in the body - to prevent and manage human disease. \n \nThe aim of OptiBiotix is to discover and develop microbial strains, compounds and formulations, which modulate the human microbiome and can be used as food ingredients and supplements or active compounds for the prevention and management of human metabolic diseases, examples of which include obesity, cholesterol and lipid distribution and diabetes. \n \nOptiBiotix has established a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression. The dev...